ArticlePharmacogenomics and personalized medicine2021

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients.

Ji Eun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.